Lupus Nephritis
📧 Sign up to get email alerts when something new happens for Lupus Nephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN) [Phase 2]
Phase 2 trial evaluating obinutuzumab versus placebo in lupus nephritis has completed, with results posted in February 2020.
-
FDA approval · 2019-11-27FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for mycophenolate mofetil submitted by Hikma Pharmaceuticals USA Inc. The approval may involve label…
-
FDA approval · 2019-11-22FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for mycophenolate mofetil submitted by Strides Pharma Science Limited, enabling regulatory updat…
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis [Phase 4]
Phase 4 trial update evaluating lower-dose prednisolone for inducing remission in lupus nephritis.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Metformin In Prevention of Lupus Nephritis [Phase 4]
A Phase 4 clinical trial investigating metformin for the prevention of lupus nephritis is listed, but current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-09-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s mycophenolate mofetil. This action updates the regulatory status for th…
-
FDA approval · 2019-09-10FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Mycophenolate mofetil (Ascend Laboratories, LLC) under an ANDA, updating the labeling for this p…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis [Phase 3]
Phase 3 trial evaluating Mizoribine for lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Rituximab and Belimumab for Lupus Nephritis [Phase 2]
Phase 2 trial update for Rituximab and Belimumab in lupus nephritis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN) [Phase 1]
Phase 1 trial update on rising doses of ixazomib for lupus nephritis focusing on safety, tolerability, and pharmacokinetics; study terminate…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis [NA]
A clinical trial evaluating autologous hematopoietic stem cell transplantation for refractory lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: The Iguratimod Effect on Lupus Nephritis (IGeLU) [Phase 2]
Phase 2 clinical trial investigating iguratimod for lupus nephritis.
-
FDA approval · 2018-08-23FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCept (mycophenolate mofetil) filed by Genentech, Inc. The approval updates the labeling and/…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN) [Phase 2]
A Phase 2 clinical trial is evaluating human umbilical cord-derived mesenchymal stem cells for lupus nephritis; the trial status is currentl…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis [NA]
The update discusses a clinical trial investigating blockade of the angiotensin II receptor with losartan in patients with lupus nephritis. …
-
CLINICAL_TRIALS withdrawal · 2018-05-11Clinical Trial Update: ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis [Phase 4]
The Phase 4 trial of ACTHAR Gel for membranous lupus nephritis (class V) has been withdrawn.
-
CLINICAL_TRIALS research · 2018-03-12Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis [NA]
A clinical trial evaluating transplantation of umbilical cord-derived mesenchymal stem cells for lupus nephritis; the current trial status i…
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis [Phase 3]
A Phase 3 trial evaluating rituximab plus mycophenolate mofetil without oral steroids for lupus nephritis was terminated.
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis [Phase 3]
Phase 3 trial evaluating abatacept for lupus nephritis was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Lupus Nephritis: Role of Environmental and Occupational Exposures
A completed clinical trial evaluating the role of environmental and occupational exposures in lupus nephritis. Sponsored by the National Ins…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease
A retrospective analysis examines renal prognosis in patients with chronic kidney disease, highlighting conditions such as diabetic nephropa…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis [Phase 2]
A Phase 2 randomized trial comparing cyclophosphamide to mycophenolate mofetil in lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis [Phase 3]
Phase 3 CHABLIS7.5 trial evaluating subcutaneous blisibimod for systemic lupus erythematosus with or without nephritis has been terminated.
-
CLINICAL_TRIALS withdrawal · 2017-04-12Clinical Trial Update: A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Lupus Nephritis Previously Enrolled in Study U2970g [Phase 3]
A Phase 3 clinical trial evaluating the safety of retreatment with rituximab in patients with lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis [Phase 4]
This Phase 4 trial compared low-dose versus high-dose cyclophosphamide as induction therapy for lupus nephritis and has completed.